FDA Approves New Drug Treatment for Nausea and Vomiting from Chemotherapy

Published in Oncology

FDA Approves New Drug Treatment for Nausea and Vomiting from Chemotherapy

I remember when I was a Principal Investigator on the team to develop Zofran -granisetron and how wonderfully this little pill with really no side effects changed the world for so many patients with chemotherapy induced nausea and vomiting. However , some of our best drugs could cause very delayed emesis and nausea and there was not a lot that worked. Let’s keep this in the context that more and more non emesis producing precision medicines, targeted therapy molecules and immune therapies are coming to the forefront. This is a VERY good thing because if the patient does well with round one they almost always are fine from there on out Dr Ryan

 The U.S. Food and Drug Administration approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting (emesis). Varubi is approved in adults in combination with other drugs (antiemetic agents) that prevent nausea and vomiting associated with initial and repeat courses of vomit-inducing (emetogenic and highly emetogenic) cancer chemotherapy.
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s